Overview
VBIO market data
Price History
VBIO price chart · 1M
- O
- 0.153500
- H
- 0.153500
- L
- 0.118100
- C
- 0.118300
- Vol
- 29,619.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $0.15
- Previous Close
- $0.15
- Day High
- $0.15
- Day Low
- $0.12
- 52 Week High
- $1.26
- 52 Week Low
- $0.11
- 7 Day Return
- -4.44%
- 30 Day Return
- -56.19%
- 90 Day Return
- -84.13%
- 1 Year Return
- -87.28%
- Daily Notional Volume
- $3.5K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$19.68 Diluted earnings per share over the trailing twelve months.
- Beta
- 3.55 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -1,557.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.11 – $1.30 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $903.7K · P/B 1.34 · P/S 1.87.
Company News
Valion Bio shares are trading lower after the company announced a 1-for-25 reverse stock split.Benzinga · Aug 27, 2026, 2:37 PM
Valion Bio Announces 1-For-25 Reverse Stock Split, Effective Aug. 31Benzinga · Aug 27, 2026, 12:32 PM
8-K filing — Valion Bio, Inc. (VBIO)SEC EDGAR · Aug 27, 2026, 12:30 PM
Why Cadeler Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving PremarketBenzinga · Aug 25, 2026, 9:25 AM
Valion Bio shares are trading lower. The company announced that Ukraine's Ministry of Health has accepted its regulatory dossier for Entolimod for formal review under the country's Regulatory Equivalence Pathway.Benzinga · Aug 13, 2026, 6:24 PM
Why Omeros Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving PremarketBenzinga · Aug 13, 2026, 9:16 AM
Valion Bio Says AFRRI Under NIAID Contract To Begin Government-Funded Entolimod Safety Study This Week For Radiation-Induced GI Injury; Top-Line Therapeutic Data Expected In Early FallBenzinga · Aug 12, 2026, 1:33 PM
Ukraine's Ministry Of Health Accepts Valion Bio's Regulatory Dossier For Entolimod For Formal Review Under Regulatory Equivalence PathwayBenzinga · Jul 22, 2026, 11:47 AM
Valion Bio shares are trading lower. The company announced a clinical development milestone with the finalization of a clinical trial protocol at Sheba Medical Center.Benzinga · Jul 20, 2026, 6:20 PM
Valion Bio To Carry Out Study At Sheba Medical Center To Mull Entolimod In 10 Cancer ParticipantsBenzinga · Jul 20, 2026, 5:35 PM